Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
NLS Pharmaceutics Ltd. (NLSP) had Return on Investments of -140.85% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-4.06M |
|
-- |
|
-- |
|
$4.38M |
|
$-4.38M |
|
$2.40M |
|
$-1.98M |
|
$-1.98M |
|
$-1.98M |
|
$-1.98M |
|
$-1.98M |
|
$-1.98M |
|
$-4.38M |
|
$-4.38M |
|
1.54M |
|
1.54M |
|
$-2.63 |
|
$-2.63 |
|
| Balance Sheet Financials | |
$2.23M |
|
$0.01M |
|
$0.01M |
|
$2.23M |
|
$0.83M |
|
-- |
|
-- |
|
$0.83M |
|
$-1.33M |
|
$1.41M |
|
$1.41M |
|
3.16M |
|
| Cash Flow Statement Financials | |
$-4.27M |
|
$-0.00M |
|
$5.04M |
|
$0.90M |
|
$1.67M |
|
$0.77M |
|
$0.13M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.69 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.27M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
148.42% |
|
-140.85% |
|
-88.70% |
|
|
Return on Investments |
-140.85% |
$0.45 |
|
$-2.77 |
|
$-2.77 |
|